Lung Diseases, Interstitial
Showing 9976 - 10000 of >10,000
SCLC, NSCLC Trial (MILs™ in Combination with Pembrolizumab)
Withdrawn
- SCLC
- NSCLC
- MILs™ in Combination with Pembrolizumab
- (no location specified)
Oct 1, 2021
Heart Failure Trial
Not yet recruiting
- Heart Failure
- (no location specified)
Jul 25, 2023
Mortality and Complications After Lung Surgery, Open Thoracic
Recruiting
- Morality
- +3 more
- Lung surgery
- +3 more
-
Bangkoknoi, Bangkok, ThailandAnesthesiology Department Siriraj Hospital
Oct 23, 2021
Lung Cancer, Mesothelioma Trial in Orbassano (niraparib and dostarlimab)
Recruiting
- Lung Cancer
- Mesothelioma
- niraparib and dostarlimab
-
Orbassano, Turin, ItalyAOU San Luigi- Department of Oncology
Oct 6, 2021
NSCLC, Advanced Cancer Trial in France (Usual care, Optimization of the medical decision)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Advanced Cancer
- Usual care
- Optimization of the medical decision
-
Abbeville, France
- +24 more
Aug 19, 2022
Lung Inflammation in Post-COVID-19 Recovery
Recruiting
- COVID-19
- Acute Respiratory Distress Syndrome
- LLLT Photobiomodulation
-
Berkeley, California
- +6 more
Feb 24, 2022
Metastatic Non-Small Lung Cell Cancer, Recurrent Non-Small Lung Cell Cancer, Stage IV Lung Cancer AJCC v8 Trial in Atlanta
Recruiting
- Metastatic Non-Small Lung Cell Cancer
- +4 more
- Docetaxel
- +2 more
-
Atlanta, GeorgiaWinship Cancer Institute of Emory University
Oct 19, 2022
Chronic Obstructive Pulmonary Disease and Domestic Endotoxin
Completed
- Chronic Obstructive Pulmonary Disease
-
Baltimore, MarylandKarina Romero
Jun 21, 2019
Bone Infection, Joint Infection, Bone and Joint Infection Trial in Torrance (Omadacycline Pill, Standard of Care)
Not yet recruiting
- Bone Infection
- +2 more
- Omadacycline Pill
- Standard of Care
-
Torrance, CaliforniaHarbor-UCLA Medical Center
Mar 1, 2023
Cardiac Allograft Vasculopathy Trial in Los Angeles (Macitentan)
Recruiting
- Cardiac Allograft Vasculopathy
-
Los Angeles, CaliforniaRonald Regan UCLA Medical Center
May 9, 2022
Complementary And Alternative Medicine During The COVID-19
Completed
- Complementary Therapies
- Complementary And Alternative Medicine
-
Gaziantep, Lütfen Seç, TurkeyHasan Kalyoncu Ünivrsitesi
May 7, 2021
Long-term Commitment to Physical Activity After Two Different
Not yet recruiting
- Chronic Disease
- Physical activities in hospital
- Physical activity outside hospital
- (no location specified)
Jul 5, 2021
LUS to Assess Lung Injury After Lung Lobectomy
Unknown status
- Lung Neoplasm
- +8 more
- Thoracotomy
- VATS
-
Valencia, SpainHospital General Universitario de Valencia
Feb 15, 2021
HIV Infection Primary, Hepatitis, Viral, Human, Sexually Transmitted Infections, Excluding HIV and Hepatitis Trial in Seville
Enrolling by invitation
- HIV Infection Primary
- +2 more
- Tenofovir Disoproxil Fumarate 300 MG Oral Tablet
-
Seville, Andalusia, SpainVirgen del Rocío University Hospital
Aug 5, 2022
Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic
Active, not recruiting
- Cholestasis
- Red Cell Membrane and Enzyme Abnormalities
- ektacytometry of red blood cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 12, 2022
Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Ziv-Aflibercept 25 MG/ML [Zaltrap]
-
Tanta, El Gharbia, EgyptTanta University
Oct 4, 2021
Sarcopenia Trial in Derby (Super-Whey protein, Isonitrogenous whey protein)
Completed
- Sarcopenia
- Super-Whey protein
- Isonitrogenous whey protein
-
Derby, United KingdomCentre of Ageing, Metabolism and Physiology
Jan 17, 2023
Screening for Alpha Thalassemia in Healthy Volunteers
Recruiting
- Alpha Thalassemia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Atopic Diseases Trial in Worldwide (Hydrolyzed Formula, Control formula)
Active, not recruiting
- Atopic Diseases
- Hydrolyzed Formula
- Control formula
-
Sofia, Bulgaria
- +13 more
Aug 24, 2021
Rehabilitation Trial in Guangzhou (ACBT training, acpella®PEP, EDP-type II external diaphragm pacemaker)
Recruiting
- Rehabilitation
- ACBT training
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat sen University cancer center
Jun 3, 2021
Asthma Trial in Antwerpen (CHF 5993 HS 200/6/25 pMDI, CHF 5993 MS 100/6/25 pMDI, CHF 5993 HS 200/6/25 pMDI + Charcoal Block)
Completed
- Asthma
- CHF 5993 HS 200/6/25 pMDI
- +4 more
-
Antwerpen, BelgiumSGS CPU Antwerpen
Jun 30, 2021
Lung Cancer Trial in Hangzhou (sintilimab and anlotinib)
Active, not recruiting
- Lung Cancer
- sintilimab and anlotinib
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 29, 2022
NSCLC Stage I, Surgery, Stereotactic Body Radiation Therapy Trial in Québec (Anatomical Segmentectomy, Lobectomy or Bilobectomy,
Withdrawn
- Non-small Cell Lung Cancer Stage I
- +2 more
- Anatomical Segmentectomy, Lobectomy or Bilobectomy
- Stereotactic Body Radiation Therapy
-
Québec, Quebec, Canada
- +1 more
Aug 17, 2021
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022